|
EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor
|
CHEBI_77106 |
|
|
EC 1.10.2.* (oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor) inhibitor
|
CHEBI_77105 |
|
|
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
|
CHEBI_65239 |
|
|
pancreatic gastrinoma
|
DOID_5580 |
|
|
islet cell tumor
|
DOID_1799 |
|
|
inserted
|
BAO_0000641 |
|
|
EC 3.4.21.5 (thrombin) inhibitor
|
CHEBI_65232 |
|
|
conjunctivochalasis
|
DOID_4250 |
|
|
melorheostosis
|
DOID_4253 |
|
|
Alexander disease
|
DOID_4252 |
|
|
Caffey disease
|
DOID_4257 |
|
|
calcium redistribution assay
|
BAO_0000649 |
|
|
ion redistribution assay
|
BAO_0000819 |
|
|
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor
|
CHEBI_77108 |
|
|
parental cell line assay
|
BAO_0000647 |
|
|
EC 1.21.3.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor) inhibitor
|
CHEBI_77109 |
|
|
truncated
|
BAO_0000644 |
|
|
point mutated
|
BAO_0000642 |
|
|
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor
|
CHEBI_77111 |
|
|
EC 1.21.3.3 (reticuline oxidase) inhibitor
|
CHEBI_77110 |
|
